Search

for
Search:

Did you mean Anti-Müllerian Hormone?

GlossaryAnti-Müllerian Hormone

protein hormone indicating ovarian reserve and aiding male fetal development

Anti-Müllerian Hormone (AMH) is a protein hormone produced by cells in the ovaries and testes. In women, AMH levels are often used as a marker of ovarian reserve, which can help assess fertility potential. In men, it plays a crucial role in the development of the male reproductive system during fetal development by inhibiting the formation of female reproductive structures.

Related Terms

Sort by

Research

30 / 458 results

Anti-Müllerian Hormone Gene Polymorphism Is Associated With Androgen Levels in Chinese Polycystic Ovary Syndrome Patients With Insulin Resistance

research Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance

12 citations , January 2016 in “Journal of Assisted Reproduction and Genetics”

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

research The role of antimullerian hormone in the hormonal workup of women with persistent acne

8 citations , June 2016 in “Journal of Cosmetic Dermatology”

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

research Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age

4 citations , May 2022 in “BMC Women's Health”

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Anti-Müllerian Hormone Confirms the Novel Classification of Female Functional Androgenization Including Polycystic Ovary Syndrome

research Anti-Müllerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome

12 citations , August 2011 in “European Journal of Endocrinology”

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The Prevalence of Polycystic Ovary Syndrome in a Normal Population According to the Rotterdam Criteria Versus Revised Criteria Including Anti-Mullerian Hormone

research The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone

221 citations , January 2014 in “Human Reproduction”

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet-Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients

research Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients

31 citations , March 2020 in “International Journal of Regenerative Medicine”

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Relationship Between Serum Anti-Müllerian Hormone and Intrafollicular AMH Levels in PCOS Women

research Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women

28 citations , September 2017 in “Gynecological Endocrinology”

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

research Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent

18 citations , October 2022 in “Biomedicines”

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Age-Specific Cut-Off Levels of Anti-Müllerian Hormone as Diagnostic Markers for Polycystic Ovary Syndrome

research Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome

8 citations , May 2021 in “Reproductive Biology and Endocrinology”

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Comparison of Vitamin 25(OH)D and Anti-Müllerian Hormone Status in Infertile Patients with Polycystic Ovary Syndrome and Diminished Ovarian Reserve

research Comparison of Vitamin 25(OH)D and Anti-Müllerian Hormone Status in Infertile Patients with Polycystic Ovary Syndrome and with Diminished Ovarian Reserve

August 2023 in “İzmir tepecik eğitim hastanesi dergisi”

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

research Canine Sertoli cell tumor: anti-Müllerian hormone, inhibin B, and estrone sulphate

April 2023 in “Clinical theriogenology”

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Effect of Gingivitis on Anti-Mullerian Hormone in Females with Polycystic Ovary Syndrome

research Effect gingivitis on anti-mullierian hormone in females with polycystic ovary syndrome

September 2018 in “International journal of biosciences”

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

research Polikistik Over Sendromlu Adölesanlarda Serum Ürokortin 2, Ürokortin 3 ve Antimüllerian Hormon Düzeyleri

May 2018 in “DergiPark (Istanbul University)”

Hormone levels studied are not linked to PCOS.

research Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome

30 citations , January 2019 in “Clinical Endocrinology”

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Accuracy of Anti-Müllerian Hormone and Total Follicle Count to Diagnose Polycystic Ovary Syndrome in Reproductive Women

research Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women

13 citations , August 2018 in “Taiwanese Journal of Obstetrics & Gynecology”

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Anti-Mullerian Hormone: A Potential Marker for Recruited Non-Growing Follicles of Ovarian Pool in Women with Polycystic Ovarian Syndrome

research Anti Mullerian Hormone: A Potential Marker for Recruited Non Growing Follicle of Ovarian Pool in Women with Polycystic Ovarian Syndrome

6 citations , January 2013 in “Journal of Clinical and Diagnostic Research”

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

research Anti-Mullerian Hormone as A new Marker for Diagnosis of Poly Cystic Ovary Syndrome

2 citations , October 2019 in “The Egyptian Journal of Hospital Medicine”

AMH is a reliable marker for diagnosing PCOS.

research The Relationship between Serum Levels of Anti-Mullerian Hormone and Body Mass Index in Adolescents with Polycystic Ovary Syndrome

1 citations , January 2020

AMH levels in adolescents with PCOS are not affected by their weight.

Evaluation of the Efficacy and Threshold of Serum Anti-Mullerian Hormone Levels for Diagnosis and Prediction of Polycystic Ovary Syndrome Among Indian Women

research Evaluation of the Efficacy and Threshold of Serum Anti-mullerian Hormone (AMH) Levels for Diagnosis and Prediction of Polycystic Ovary Syndrome (PCOS) Among Indian Women.

January 2022 in “Research Square (Research Square)”

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

research Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome

15 citations , September 2023 in “International Journal of Microbiology Research”

research Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters

10 citations , September 2022 in “Indian Journal of Clinical Biochemistry”

research Effects of High-dose Radioactive Iodine Therapy on Hormonal Profiles and Sperm Quality in Thyroidectomy Patients

February 2026 in “Molecular Imaging and Radionuclide Therapy”

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

research Diagnosis of polycystic ovaries syndrome: establishment of reference values of nine hormones on Maglumi X- 8

April 2025 in “Middle East Fertility Society Journal”

Reference values for nine hormones were established to help diagnose PCOS.

research The effect of laparoscopic ovarian drilling on the serum levels of AMH, FSH, LH and Testosterone hormones, in patients with PCOS

June 2019 in “The Medical journal of Basrah University”

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

research A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome

98 citations , May 2020 in “Journal of Functional Morphology and Kinesiology”

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

research In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond

44 citations , September 2020 in “International Journal of Molecular Sciences”

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

research Evaluation of Female Fertility—AMH and Ovarian Reserve Testing

53 citations , February 2022 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

research Endocrine profile of the VCD-induced perimenopausal model rat

21 citations , December 2019 in “PloS one”

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

research Abstract 14

9 citations , November 2014 in “Indian Journal of Endocrinology and Metabolism”

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Can AMH Levels Distinguish LOCAH from PCOS Among Hirsute Women?

research May AMH levels distinguish LOCAH from PCOS among hirsute women?

5 citations , April 2014 in “European Journal of Obstetrics & Gynecology and Reproductive Biology”

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.